Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study.

"CSL Vifor funded the study report, the contents of which are given in this manuscript, produced by Vifor Pharma Group and CliCon S.r.l. Benefit Society. The opinions expressed here are those of the authors and not necessarily those of the funders. The agreement signed by CliCon S.r.l. and Vifor Pharma Group does not create any entity, joint venture or any other similar relationship between the parties. CliCon S.r.l. is an independent company. Neither CliCon S.r.l. nor any of its representatives are employees of CSL Vifor in any capacity. Antonio Ramirez de Arellano Serna and Neige Morin are employees of CSL Vifor. Ioannis Koutroubakis has served as advisory board member for AbbVie, Genesis, Janssen, MSD, Pfizer, Shire, Takeda and Vifor; Speaker for AbbVie, Genesis, Janssen, MSD, Vianex and Takeda; research support AbbVie, Vianex and Ferring. All the other co-authors have no conflicts of interest to disclose in this work."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by funding from CSL Vifor."